Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic GMP levels in interferon treated cells.

C Rochette-Egly, M G Tovey

    Antiviral Research
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Interferon (IFN) can increase cyclic GMP in various cells, but this rise doesn't mediate its main biological effects. Cell-type differences in cyclic GMP response may reflect varying IFN sensitivity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.

    Leukemia·2012
    Same author

    A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK.

    Oncogene·2011
    Same author

    Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2008
    Same author

    Dysregulation of elastin expression by fibroblasts in pulmonary emphysema: role of cellular retinoic acid binding protein 2.

    Thorax·2008
    Same author

    Quantification of neutralizing antibodies to human type I interferons using division-arrested frozen cells carrying an interferon-regulated reporter-gene.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2008
    Same author

    Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB.

    Oncogene·2006
    Same journal

    Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention.

    Antiviral research·2026
    Same journal

    The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

    Antiviral research·2026
    Same journal

    Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

    Antiviral research·2026
    Same journal

    ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

    Antiviral research·2026
    Same journal

    Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

    Antiviral research·2026
    Same journal

    Effects of RNA polymerase inhibitors on nucleotidylylation of human norovirus VPg.

    Antiviral research·2026
    See all related articles

    Area of Science:

    • Immunology
    • Cell Biology
    • Molecular Biology

    Background:

    • Interferons (IFNs) are crucial cytokines with diverse biological activities, including antiviral and antiproliferative effects.
    • The precise molecular mechanisms underlying IFN actions are complex and involve various signaling pathways.
    • Elevated cyclic guanosine monophosphate (cGMP) levels have been observed in response to IFN in some cell types.

    Purpose of the Study:

    • To investigate the relationship between interferon treatment and cyclic GMP (cGMP) levels across different cell types.
    • To determine if elevated cGMP is a universal mediator of interferon's principal biological actions.
    • To explore potential correlations between cell sensitivity to interferon and cGMP response.

    Main Methods:

    • Cell cultures of various types, including lymphoid cells (pre-T, natural killer, B lymphocytes), neurons, erythroid cells, and fibroblasts (normal and Down's syndrome fibroblasts).

    Related Experiment Videos

  • Treatment of cultured cells with interferon.
  • Measurement of intracellular cyclic GMP (cGMP) levels following interferon exposure.
  • Assessment of interferon's antiviral effects.

    • Main Results:

    • Various normal and neoplastic lymphoid cells, neurons, and erythroid cells showed elevated cGMP levels upon interferon treatment.
    • Human pre-T and natural killer cells were more sensitive to this cGMP-elevating effect than B lymphocytes.
    • Fibroblasts, while responsive to interferon's antiviral effects, did not elevate cGMP, except for fibroblasts from Down's syndrome patients (trisomic for chromosome 21).
    • Down's syndrome fibroblasts exhibited enhanced cGMP levels post-interferon, correlating with their increased sensitivity to interferon's antiviral action.

    Conclusions:

    • The increase in cyclic GMP (cGMP) levels does not appear to mediate the principal biological actions of interferon (IFN).
    • The differential ability of cell types to increase cGMP in response to IFN may indicate varying degrees of IFN sensitivity rather than an inability to respond.
    • These findings highlight the complexity of IFN signaling and suggest that cGMP elevation is not a universal downstream effect for all IFN-mediated biological responses.